01 3Pfizer Canada Inc.
02 3Blank
01 31253865
02 32170278
01 3Amlodipine Besylate
02 3Blank
01 3Tablet
02 3Blank
01 32006-05-09
02 32014-08-10
Patent Expiration Date : 2014-08-10
Date Granted : 1999-08-03
Brand Name : NORVASC
Patent Number : 2170278
Filing Date : 1994-08-10
Strength per Unit : 2.5 mg / tablet
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-08-10
Date Granted : 1999-08-03
Patent Expiration Date : 2014-08-10
Date Granted : 1999-08-03
Brand Name : NORVASC
Patent Number : 2170278
Filing Date : 1994-08-10
Strength per Unit : 5 mg / tablet
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-08-10
Date Granted : 1999-08-03
Patent Expiration Date : 2014-08-10
Date Granted : 1999-08-03
Brand Name : NORVASC
Patent Number : 2170278
Filing Date : 1994-08-10
Strength per Unit : 10 mg / tablets
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-08-10
Date Granted : 1999-08-03
Patent Expiration Date : 2006-05-09
Date Granted :
Brand Name :
Patent Number : 1253865
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2006-05-09
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2006-05-09
Date Granted :
Brand Name :
Patent Number : 1253865
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2006-05-09
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2006-05-09
Date Granted :
Brand Name :
Patent Number : 1253865
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2006-05-09
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?
Market Place
